Mammalian anti proliferative signals and their targets

Current Opinion in Genetics and Development

Volumn 5, Issue 1, 1995, Pages 91-96

  Massague, Joan ^a   Polyak, Kornelia ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DERIVATIVE; CYCLINE; CYTOTOXIC AGENT; MITOGENIC AGENT; PHOSPHOTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

AMINO ACID SEQUENCE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; DNA REPLICATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE MUTATION; HUMAN; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; REVIEW; SIGNAL TRANSDUCTION;

ANIMAL; CELL CYCLE; CYCLIN-DEPENDENT KINASES; G1 PHASE; GENES, TUMOR SUPPRESSOR; HUMAN; MITOGENS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0028959979     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(95)90059-4     Document Type: Article

References (51)

1. The transforming growth factor betas
2. The Transforming Growth Factor-beta Family
3. What do BMPs do in mammals? Clues from the mouse short-ear mutation
4. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights
5. A link between cyclin A expression and adhesion-dependent cell cycle progression
6. Physiological actions and clinical applications of transforming growth factor-β (TGF-β)
7. Reversible inhibition of mammary gland growth by transforming growth factor-β
8. TGF-β1 Inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming protein with pRB binding domains
9. Growth inhibition by TGF-β1 linked to suppression of retinoblastoma protein phosphorylation
10. TGF-β induces myoblast differentiation in the presence of mitogens
11. Molecular controls of apoptosis: differentiation/growth arrest primary response genes, protooncogenes and tumor suppressor genes as positive and negative modulators
12. The TGF-β family and its composite receptors
13. Signal transduction by receptors with tyrosine kinase activity
14. Transforming growth factorlatent forms, binding proteins and receptors
15. Receptors for the TGF-β superfamily
16. Determination of type 1 receptor specificity by the type II receptors for TGF-β and activin
17. Identification of human activin and TGF-β type I receptors that form heteromeric kinase complexes with type II receptors
18. Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor
19. A transforming growth factor β type 1 receptor that signals to activate gene expression
20. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
21. Mechanism of activation of the TGF-β receptor
22. Reconstitution and transphosphorylation of TGF-β receptor complexes
23. TGF-β receptors and actions
24. Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor
25. G1 events and the regulation of cell proliferation
26. The ins and outs of Rb: coupling gene expression to the cell cycle clock
27. Mammalian G1 cyclins
28. Cyclins, Cdks and cyclin kinase inhibitors
29. Colony-stimulation factor 1 regulates novel cyclins during the G1 phase of the cell cycle
30. TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest
31. Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases
32. A novel inhibitor of cyclin-cdk activity detected in transforming growth factor β-arrested epithelial cells
33. Suppression of growth factor-induced CYL-1 cyclin gene expression by antiproliferative agents
34. FKBP-rapamycin inhibits-a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line
35. cdc2 kinase activation in T lymphocytes
36. Negative regulation of G1 in mammalian cells: inhibition of cyclin Edependent kinase by TGF-β
37. p27Kipl, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest
38. Cloning of p27Kipl, a cyclin-cdk inhibitor and a potential mediator of extracellular antimitogenic signals
39. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
40. The p21 cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases
41. WAFT, a potential mediator of p53 tumor suppression
42. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
43. Cloning of Senescent Cell-Derived Inhibitors of DNA Synthesis Using an Expression Screen
44. p21 is a universal inhibitor of cyclin kinases
45. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4
46. INK48 is a potential effector of TGF β-induced cell cycle arrest
47. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation
48. Rapamycin prevents IL-2-mediated elimination of the cyclin-CDK kinase inhibitor, p27Kip1
49. Resistance to inhibition of cell growth by transforming growth factor-β and its role in oncogenesis
50. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
51. A cell cycle regulator potentially involved in genesis of many tumor types